Heart disease is a major health issue worldwide. February was established as the month of heart health awareness in the US, UK and other countries to raise public awareness about cardiovascular health.

For the past 30 years, cardiovascular disease has been the number one cause of death worldwide and the leading cause of death for people aged 15 years and above. Cardiovascular disease is responsible for more than one third of annual global deaths and in 2019, approximately 18 million people lost their lives due to cardiovascular complications. A significant percentage of 80% of all cardiovascular deaths are caused by a heart attack or a stroke and 36% of those heart attack and stroke deaths are people under the age of 70.

Cardiovascular diseases are one of the most common yet one of the most complicated health challenges around the globe. Cardiovascular disease can be used to refer to a variety of diseases affecting the heart and its blood vessels. Some of the most common ones are heart failure, coronary heart disease (commonly known as heart attack), hypertension and cerebrovascular disease (stroke). Until now, the risk of developing a cardiovascular disease was calculated using lifestyle factors such as high body mass index (BMI), smoking, physical inactivity, and high blood cholesterol. In recent years, emphasis has also shifted towards hereditary genetic factors. Research shows that people can inherit genetic mutations which could potentially result in a compromised cardiovascular system. Genetic testing is the process of analyzing cells or tissue to look for changes (mutations) in genes, chromosomes, or proteins that may be a sign of a disease or condition; and it plays a vital role in early detection. People diagnosed at an early stage have the best prognosis by undergoing therapies or adapting significant lifestyle changes.

At least one third of worldwide heart attacks and strokes are preventable. Cardiovascular genetic tests are an efficient and accurate way to get an insight about your cardiovascular health. People with an inherited genetic mutation have a predisposition to developing a life-threatening condition in the future. The genetic mutation is present since birth but can manifest any time. Genetic screening can inform individuals of their risk to develop a cardiovascular disease and help avoid future complications that might be irreversible. Genetic screening is recommended by several associations such as European Society of Cardiology and American Heart Association.

Early detection and clinical management is key to preventing sudden cardiovascular episodes. Clinical testing can identify high risk patients through chemical analysis of biological markers (biomarkers). A biomarker is a characteristic that can be measured and evaluated as an indicator of a biological state or condition. Common biomarkers used to identify high risk individuals are LDL, HDL, total cholesterol, triglycerides, apolipoproteins, and ferritin levels. Each of these biomarkers serves as an indicator and depending on their levels, advice or medication is given to limit or eliminate the risk of developing or worsening a cardiovascular disease.

Scientific research has led to the discovery of a wide range of biomarkers linked to cardiovascular health risks and cardiovascular disease prevention. Novel cardiovascular biomarkers include substances such as enzymes, hormones, and proteins, that are released into the bloodstream in the event of stressed or damaged heart. An example of a novel cardiovascular biomarker is troponin, a group of proteins that regulate the contractions of the heart and skeletal muscles, with a high sensitivity and longer presence in the blood that any other biomarker, making it the best way to diagnosing a heart attack. Hemoglobin is one of the most widely measured biomarkers as it reflects up to 3 months of glucose levels in the blood of patients suffering from diabetes. High-sensitivity C-reactive protein is another novel biomarker as it indicates any severe ongoing inflammation and B-type natriuretic peptide is a biomarker that indicates a myocardial wall stress.

Advancements in research and analysis on novel biomarkers, as well as genetic testing to identify hereditary genetic mutations, can be key to early detection, better prognosis and reliable clinical management of cardiovascular diseases.

View All Posts

NIPD Genetics - Privacy Policy

General Statement

This Privacy Policy applies only to www.nipd.com and its subdomains (hereafter collectively referred to as “Sites") that link to this policy. NIPD Genetics Sites are owned by NIPD Genetics Public Company Ltd and are operated by NIPD Genetics Public Company Ltd and on occasion by a third-party that is responsible for the technical maintenance of the Sites.

If, you do not agree with this Privacy Policy, please do not access or use any of NIPD Genetics Sites.

NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.

Personal data for purposes of this Privacy Policy, is any information by which you can be individually identified, including, but not limited to, your name, profession, address, e-mail address, and telephone number.

You may contact NIPD Genetics Public Company Ltd at
NIPD Genetics Public Company Ltd
Neas Engomis 31
Engomi, Nicosia
2409, Cyprus

NIPD Genetics Data Protection Officer can be reached at dpo@nipd.com

This Privacy Policy applies only to the Sites as defined above and which are operated by NIPD Genetics. The NIPD Genetics Privacy Policy seeks to inform the users of its Sites of the following:

NIPD Genetics will not use or share your information with anyone, except as described in this Privacy Policy. This Privacy Policy does not apply to any information we might collect by other digital and offline means and or from other digital and offline sources. The use of information collected through our Sites shall be limited to the purposes under this Privacy Policy and our Terms of Use to customers.

This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.

We use your data to provide and improve the Sites. By using the Sites, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from www.nipd.com

Type of personal information NIPD Genetics may collect through its Sites

Information Collection And Use

We collect several different types of information for various purposes to provide and improve our Sites and services to you.

Personal Data

While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:

If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.

Cookies and Usage Data

Usage Data

We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Sites and hold certain information.

Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.

Examples of Cookies we use:

Session Cookies. We use Session Cookies to operate our Sites.

Preference Cookies. We use Preference Cookies to remember your preferences and various settings.

Security Cookies. We use Security Cookies for security purposes.

Visitor behavior cookies. To understand how visitors use and navigate the Sites

Keyword cookies. To understand how visitors discover the Sites.

Use of Data

www.nipd.com uses the collected data for various purposes:

Transfer of Data

Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

www.nipd.com will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.

NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:

Security of Data

The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Service Providers

We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.


We may use third-party Service Providers to monitor and analyze the use of our Sites.

Google Analytics

Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.

You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.

For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page

Access to your personal data, correction, deletion, and Opting Out

You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer pdo@nipd.com

Links to Other Sites

Our Sites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.

Children's Privacy

Our Service does not address anyone under the age of 18 ("Children").

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the "effective date" at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact pdo@nipd.com

Ok got it!